SeLENOZYME, located in Sweden, is the World’s first specialized for recombinant production of active Selenoproteins.
SeLENOZYME uses a cutting-edge technology, resulting from over 30 years of research at Karolinska Institutet in Stockholm, Sweden. Their recombinant system allows for production of purified and active selenoproteins. Their portfolio includes more than 25 selenoproteins.
Since all selenoproteins by definition contain the rare amino acid Selenocysteine (Sec), it has previously been very hard to obtain them in pure form or to produce them recombinantly, due to the complex genetic system required for co-translational Sec insertion.
Their recombinant production system uses bacteria instead of mammalian cells, making the production of active selenoproteins more effective and cost-efficient.